Martina Sluga-O’Callaghan

Articles by Martina Sluga-O’Callaghan

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer

ByRavi K. Goyal,Jingchuan Zhang,Samina Dhuliawala,Martina Sluga-O’Callaghan,Peter A. Kaufman, MD

April 18th 2022

Latest Updated Articles

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer
April 18th 2022

Trending on CancerNetwork

Belzutifan Combo Receives FDA Approval in Advanced Clear Cell RCC

Emerging Endocrine Doublets and Serial ESR1 Testing in HR+/HER2− mBC

Daratumumab Combo Yields Responses in Cardiac-Involved AL Amyloidosis Trials

Epcoritamab Combo Receives Canadian Approval in R/R Follicular Lymphoma

SOHO-02 Trial Will Confirm Sevabertinib’s Frontline NSCLC Benefit